SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma Science informs about change of RTA

17 Dec 2020 Evaluate

With reference to its earlier letter dated March 18, 2020, about change in Registrar and Transfer Agent (RTA). As required under Regulation 7 (4) & (5) of SEBI (LODR) Regulations, 2015, Solara Active Pharma Science has informed that the company have entered into a tripartite agreement with Cameo Corporate Services (Present RTA) & Kfin Technologies (Former RTA) dated December 15, 2020.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

499.25 9.95 (2.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×